Ariana Grande tweets she is 'broken' over blast following her concert at Manchester ArenaWorld May 23, 8:03
British PM to chair meeting of emergency response committee after Manchester blastWorld May 23, 7:53
Anti-corruption fight in Russia is in earnest, says upper house speakerRussian Politics & Diplomacy May 23, 6:24
British prime minister calls Manchester blast 'appalling terrorist attack'World May 23, 5:52
At least 19 people confirmed dead in Manchester Arena blastWorld May 23, 4:40
Senator: Ukrainian authorities reluctant to stop policy of restricting Ukrainians' rightsRussian Politics & Diplomacy May 23, 3:48
Maestro Gergiyev’s orchestra opens international music festival in SofiaSociety & Culture May 23, 3:44
Anti-Russian sanctions unlikely to be lifted shortly, says parliament speakerBusiness & Economy May 23, 2:33
Senior Russian MP says too early to speak of thaw in Russia-US tiesRussian Politics & Diplomacy May 23, 2:26
LONDON, June 14. /TASS/. Russian tennis star Maria Sharapova said she would file an appeal with the Court of Arbitration for Sports (CAS) against her two-year suspension, imposed last week by the International Tennis Federation’s (ITF) Tribunal over anti-doping violations, Britain’s web portal Sky News reported on Tuesday.
In early March, Sharapova announced that her doping tests revealed the presence of performance enhancing drug meldonium in the body system. Following the announcement, former World’s No. 1 was provisionally suspended from all tennis-related activities.
The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
WADA announced on April 13 that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.